Rafael and Curesponse to Collaborate on Precision Oncology Platform

HAIFA, Israel, Feb. 4 (Korea Bizwire) — Curesponse (www.curesponse.com) and Rafael (https://www.rafael.co.il/) to collaborate on integrating Artificial Intelligence capabilities in precision oncology platform.  This collaboration combines Rafael’s vast array of combat-proven AI and Machine Learning capabilities with Curesponse’s cutting-edge, personalized oncology technologies in the fields of Drug Response, the Tumor Microenvironment (TME), and Molecular Biology [...]